Kalvista Pharmaceuticals Inc (KALV)
Stock-Based Compensation
$0.00
Quarterly · Period ending: · USD
KALV Stock-Based Compensation
Latest reported$0.00period ending
Latest reported$0.00period ending
KALV Quarterly Stock-Based Comp ($64.00K → $0.00)
Quarterly stock-based compensation
High-resolution chart · PNG
KALV stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 5,379,000 | |
| -8,649,000 | |
| 2,610,000 | |
| 0 | |
| 3,040,000 | |
| 12,743,000 | |
| 2,711,000 | |
| 3,207,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 2,642,000 | |
| 0 | |
| 2,777,000 | |
| 2,860,000 | |
| 0 | |
| 3,441,000 | |
| 1,241,000 | |
| 0 | |
| 0 | |
| 1,090,000 | |
| 1,122,000 | |
| 1,162,000 | |
| 1,074,000 | |
| 846,000 | |
| 797,000 | |
| 976,000 | |
| 347,000 | |
| 281,000 | |
| 285,000 | |
| 273,000 | |
| 221,000 | |
| 166,000 | |
| -67 | |
| 282,000 | |
| 312,000 | |
| 368,000 | |
| 341,000 | |
| 289,000 | |
| 37,000 | |
| 118,000 | |
| 173,000 | |
| 99,000 | |
| 50,000 | |
| 59,000 | |
| 64,000 |